MTOR and pancreatic neoplasm: Diminished expression of m1A and its regulatory enzyme ALKBH1 in pancreatic cancer correlates with a dire prognosis, expediting disease progression via the mTOR and Erythroblastic Leukemia Viral Oncogene Homologs (ErbB) signaling pathways [116].